FDA Approved: MITOXANTRONE — Supplemental Application (Meitheal Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for mitoxantrone from Meitheal Pharmaceuticals Inc., updating the approved generic product under the ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Hormone-refractory Prostate Cancer
• Multiple Sclerosis

Drugs mentioned

• Mitoxantrone (mitoxantrone)

Snippet

SUPPL AP for MITOXANTRONE (MITOXANTRONE)